Drug Trial Radar · NCT06561386
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Last checked: Nov 20, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Oct 7, 2024
Primary completion
Jul 30, 2030
Study completion Aug 4, 2032
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Aug 20, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1%
Conditions
- Non-small Cell Lung Cancer
Interventions
NivolumabDrug
Specified dose on specified days
RelatlimabDrug
Specified dose on specified days
PembrolizumabDrug
Specified dose on specified days
CarboplatinDrug
Specified dose on specified days
PemetrexedDrug
Specified dose on specified days
CisplatinDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall survival (OS) in randomized participants with PD-L1 1% to 49%Time frame: Up to 5 years
Locations
330 sites in 31 countries. Site status is shown where the registry gives one.
Local Institution - 0487
Mobile, Alabama · Not yet recruiting
Southern Arizona VA Health Care System
Tucson, Arizona · Recruiting
Local Institution - 0112
Los Angeles, California · Withdrawn
University of California Davis (UC Davis) Comprehensive Cancer Center
Sacramento, California · Recruiting
Local Institution - 0159
San Francisco, California · Completed
UCLA Hematology/Oncology - Santa Monica
Santa Monica, California · Recruiting
Local Institution - 0500
Grand Junction, Colorado · Not yet recruiting
Local Institution - 0472
Westminster, Colorado · Not yet recruiting
Local Institution - 0206
Miami, Florida · Completed
Local Institution - 0162
Pembroke Pines, Florida · Completed
Florida Cancer Specialists - North
St. Petersburg, Florida · Recruiting
Florida Clinical Trials Group.
Tamarac, Florida · Recruiting
Florida Cancer Specialists - East
West Palm Beach, Florida · Recruiting
Local Institution - 0509
Coeur d'Alene, Idaho · Not yet recruiting
Local Institution - 0376
Chicago Ridge, Illinois · Completed
Cancer Center of Kansas
Wichita, Kansas · Recruiting
Saint Elizabeth Medical Center Edgewood
Edgewood, Kentucky · Recruiting
Baptist Health Lexington
Lexington, Kentucky · Recruiting
Local Institution - 0502
Paducah, Kentucky · Not yet recruiting
Velocity Clinical Research, Annapolis
Annapolis, Maryland · Recruiting
Profound Research LLC - MHP MedOnc Royal Oak - Oakland Medical Group Location
Royal Oak, Michigan · Recruiting
Local Institution - 0226
Hattiesburg, Mississippi · Completed
Local Institution - 0498
Kansas City, Missouri · Not yet recruiting
Local Institution - 0308
Bozeman, Montana · Completed
Renown Regional Medical Center
Reno, Nevada · Recruiting
Local Institution - 0507
Morristown, New Jersey · Not yet recruiting
Local Institution - 0346
Paterson, New Jersey · Completed
Local Institution - 0523
Summit, New Jersey · Not yet recruiting
Local Institution - 0381
Albuquerque, New Mexico · Completed
Local Institution - 0356
Hawthorne, New York · Completed
Veterans Affairs New York Harbor Healthcare System
New York, New York · Recruiting
Local Institution - 0380
Northport, New York · Withdrawn
University of Rochester Medical Center
Rochester, New York · Recruiting
Local Institution - 0511
Schenectady, New York · Not yet recruiting
SUNY Upstate Medical University
Syracuse, New York · Recruiting
Local Institution - 0357
The Bronx, New York · Withdrawn
Local Institution - 0352
Asheville, North Carolina · Completed
East Carolina University
Greenville, North Carolina · Recruiting
Local Institution - 0369
Canton, Ohio · Withdrawn
Local Institution - 0486
Centerville, Ohio · Not yet recruiting
Showing 40 of 330 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.